|
CXORF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.624100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.982200E-01 |
| Normal-vs-Stage2 |
2.588600E-01 |
| Normal-vs-Stage3 |
1.327430E-01 |
| Normal-vs-Stage4 |
7.496000E-01 |
| Stage1-vs-Stage2 |
4.432600E-01 |
| Stage1-vs-Stage3 |
2.401600E-01 |
| Stage1-vs-Stage4 |
4.524200E-01 |
| Stage2-vs-Stage3 |
8.486800E-01 |
| Stage2-vs-Stage4 |
3.218200E-01 |
| Stage3-vs-Stage4 |
2.522000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.704500E-02 |
| Normal-vs-AfricanAmerican |
2.267400E-01 |
| Normal-vs-Asian |
6.458600E-01 |
| Caucasian-vs-AfricanAmerican |
8.456400E-01 |
| Caucasian-vs-Asian |
4.364800E-01 |
| AfricanAmerican-vs-Asian |
4.440200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.384200E-01 |
| Normal-vs-Female |
1.819280E-04 |
| Male-vs-Female |
1.823710E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.420400E-01 |
| Normal-vs-Extreme_Weight |
8.866200E-01 |
| Normal-vs-Obese |
3.891900E-02 |
| Normal-vs-Extreme_Obese |
2.818000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.837600E-01 |
| Normal_Weight-vs-Obese |
6.645400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.252600E-01 |
| Extreme_Weight-vs-Obese |
4.840300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.824200E-01 |
| Obese-vs-Extreme_Obese |
8.333600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.956570E-01 |
| Normal-vs-Age(41-60Yrs) |
9.777700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.240000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.439400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.692600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.981800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.129600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.468300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.153400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.147200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.910560E-01 |
| Normal-VS-Type2 PRCC |
2.264200E-01 |
| Normal-VS-KIRP CIMP |
5.711600E-02 |
| Normal-VS-Unclassified PRCC |
2.718400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.727800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.327400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.732100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.186000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.114600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.832400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.544000E-01 |
| Normal-vs-N1 |
1.859980E-01 |
| Normal-vs-N2 |
3.871800E-01 |
| N0-vs-N1 |
1.929610E-01 |
| N0-vs-N2 |
2.654800E-01 |
| N1-vs-N2 |
7.058400E-01 |
|
|
